Nanodelivery in airway diseases: challenges and therapeutic applications.
about
Combating Tuberculosis Infection: A Forbidding ChallengeNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesAerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery SystemsDendrimer-Based Selective Proteostasis-Inhibition Strategy to Control NSCLC Growth and ProgressionDevelopment of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosisAnalysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications.pH-sensitive strontium carbonate nanoparticles as new anticancer vehicles for controlled etoposide release.Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseasesRNAi Therapeutic Platforms for Lung Diseases.Nanocarriers for pulmonary administration of peptides and therapeutic proteins.'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs.Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.Inhalation therapy to treat pulmonary arterial hypertension.Single-particle tracking for studying nanomaterial dynamics: applications and fundamentals in drug delivery.Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols.Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Ĉerenkov imaging.Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.Magnetic Targeting and Delivery of Drug-Loaded SWCNTs Theranostic Nanoprobes to Lung Metastasis in Breast Cancer Animal Model: Noninvasive Monitoring Using Magnetic Resonance Imaging.Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models
P2860
Q26750683-E1D55D52-57B1-4120-9AE9-94D8C79F2275Q26786162-A4799406-2A10-47B6-B8B4-6F1A92E40A56Q28392004-BEFD2182-0833-4B09-9185-DD4B7B1926F8Q28552714-A98CF4E0-266C-400E-B376-2A7AF5DE3276Q34198852-E88F39E0-D89A-40E3-9A80-45C94F778F72Q34675068-1C52EE97-3C79-4A2F-A908-9F4D42FD444FQ35150539-366FC7E1-29E6-4686-A671-E6A52AFFC621Q35897573-BB4CB168-30B6-4255-9A79-CFD15B0B39BAQ36422796-321B2026-A203-4435-B926-D2FCC48BC85FQ36968187-A94E51FE-9088-4F25-841E-4BC8BF4D84D9Q37078082-A39D7B7A-8D3C-4564-8465-1C0EC7D9940FQ37277373-14C43772-9279-4B61-B87E-8B1C5DF40B27Q37823598-8A71B45D-41A6-4E9C-BFA2-A41AFC3BF0D1Q38074463-BDDBDD4F-B070-483A-8572-3274D1B935DBQ38133484-951BBF4A-E961-441D-963D-111A42AE5CA1Q38162947-DA6FD79C-8714-4F95-ABAB-759584C3966BQ38225020-4D072758-2A6A-47BC-8256-74A15712C41FQ39294479-0C1EF433-89E6-49AA-B720-704537F7F379Q39913361-4DB89524-B1EA-4338-B09A-E37F35CEFB25Q40048899-CD672FEB-FE50-4862-83BE-7AE33861C318Q42176591-A7992687-80BB-41D3-8700-75D4A80B338AQ42873072-BA9F4C83-76C9-40D4-824E-96F1F561DEB3Q51581869-AB5BB649-BED1-455F-85A4-FDC0D7E35429Q58691546-597C4F23-1B54-4FFE-9ED8-D56D8DBEC571
P2860
Nanodelivery in airway diseases: challenges and therapeutic applications.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nanodelivery in airway diseases: challenges and therapeutic applications.
@ast
Nanodelivery in airway diseases: challenges and therapeutic applications.
@en
type
label
Nanodelivery in airway diseases: challenges and therapeutic applications.
@ast
Nanodelivery in airway diseases: challenges and therapeutic applications.
@en
prefLabel
Nanodelivery in airway diseases: challenges and therapeutic applications.
@ast
Nanodelivery in airway diseases: challenges and therapeutic applications.
@en
P2860
P1476
Nanodelivery in airway diseases: challenges and therapeutic applications.
@en
P2093
Indrajit Roy
Neeraj Vij
P2860
P304
P356
10.1016/J.NANO.2009.07.001
P577
2009-07-16T00:00:00Z